Skip to content
Clinitech Laboratory logo

Clinitech Laboratory

544220 BSE
₹30.00

Close ·

View as Markdown
MCP
Close 30 Oct 2026 ₹30.00 −14.00 −31.8% 1Y
Start ₹44.00

Key Fundamentals

SMEHealthcare ServicesHealthcare

Price-based figures at the close · TTM

ROCE
7.27%
Debt to Equity
0.04
EPS (TTM)
—
Book Value
₹40.52
Market Cap
—
P/E (TTM)
—
P/B
0.74
ROE
4.65%
Dividend Yield
0.00%
EBITDA
₹1.20 Cr
52W High
₹47.15
52W Low
₹28.55

Key Insights

Strengths

2
  • Company is almost debt free.
  • Stock is trading at 0.79 times its book value

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 5.94% over last 3 years.
  • Debtor days have increased from 57.9 to 71.2 days.
  • Working capital days have increased from 99.9 days to 164 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1234
OscillatorsBullish234
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
30.86
Neutral
MACD (12,26,9)
−2.20
Bearish
SMA (50)
38.29
Bearish
SMA (200)
45.71
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y+15.81%
3Y+14.29%
1Y+15.19%

Net profit

Net profit growth by window
5Y+0.98%
3Y−11.70%
1Y+7.69%

Operating cash flow

Operating cash flow growth by window
5YTurned negative
3YTurned negative
1YOutflow widened by ₹0.02 Cr

Operating margin· change in pp

Operating margin growth by window
5Y−7.80 pp
3Y−10.98 pp
1Y+0.35 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2021₹4.55 Cr
Mar 2022₹6.38 Cr
Mar 2023₹6.35 Cr
Mar 2024₹6.40 Cr
Mar 2025₹8.23 Cr
Mar 2026₹9.48 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2021₹0.40 Cr
Mar 2022₹0.51 Cr
Mar 2023₹0.61 Cr
Mar 2024₹0.37 Cr
Mar 2025₹0.39 Cr
Mar 2026₹0.42 Cr

Half-yearly Results

₹ Cr
544220 half-yearly results, ₹ crore
Particulars Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
3.06
3.34
4.08
4.16
5.08
4.39
Expenses
2.78
2.61
3.52
3.88
4.54
3.94
Operating Profit
0.28
0.73
0.56
0.28
0.54
0.45
OPM %
9.15%
21.86%
13.73%
6.73%
10.63%
10.25%
Other Income
0.02
0.01
0.05
0.17
0.11
0.08
Interest
0.04
0.06
0.04
0.02
0.05
0.02
Depreciation
0.19
0.25
0.31
0.14
0.25
0.26
PBT
0.07
0.43
0.26
0.29
0.35
0.25
Tax %
14.29%
30.23%
15.38%
41.38%
14.29%
52%
Net Profit
0.07
0.3
0.22
0.17
0.3
0.12
EPS (₹)
0.47
1.79
0.96
0.74
1.31
0.53

Profit & Loss

₹ Cr
544220 profit and loss, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
4.55
6.38
6.35
6.4
8.23
9.48
Expenses
3.72
5.31
4.99
5.41
7.4
8.49
Operating Profit
0.83
1.07
1.36
0.99
0.83
0.99
OPM %
18.24%
16.77%
21.42%
15.47%
10.09%
10.44%
Other Income
0.04
0.07
0.02
0.04
0.23
0.19
Interest
0.08
0.06
0.07
0.09
0.06
0.07
Depreciation
0.25
0.38
0.45
0.44
0.45
0.51
PBT
0.54
0.7
0.86
0.5
0.55
0.6
Tax %
25.93%
27.14%
29.07%
26%
29.09%
30%
Net Profit
0.4
0.51
0.61
0.37
0.39
0.42
EPS (₹)
2.67
3.4
4.07
2.2
1.71
1.84
Div. Payout %
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
544220 balance sheet, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.67
1.5
1.5
1.68
2.28
2.28
Reserves
0.72
0.35
0.88
1.87
6.55
6.97
Borrowings
0.54
0.89
1.03
0.87
0
0.36
Other Liabilities
0.8
0.94
2.62
1.19
2.01
1.3
Total Liabilities
2.73
3.68
6.03
5.61
10.84
10.91
Fixed Assets
0.84
1.65
1.33
1.71
2.12
2.18
CWIP
0.08
0.41
0.56
0.94
1.01
0.99
Investments
0.09
0.14
2.02
0.07
0.07
0.08
Other Assets
1.72
1.48
2.12
2.89
7.64
7.66
Total Assets
2.73
3.68
6.03
5.61
10.84
10.91

Cash Flow

₹ Cr
544220 cash flow, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.38
0.96
1.25
−1.28
−0.88
−0.9
Investing
0.54
−1.47
−0.65
0.75
−0.73
−0.44
Financing
−0.88
0.29
0.09
0.45
3.98
0.33
Net Cash Flow
0.04
−0.22
0.68
−0.08
2.37
−1.01
Free Cash Flow
0.19
−0.55
0.97
−2.49
−1.73
−1.45
CFO/EBITDA
64
109
114
−115
−87
−70

Ratios

544220 financial ratios, annual
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
44.92
20.6
28.17
34.22
68.3
71.23
Inventory Days
32.21
40.28
43.68
92.91
—
—
Days Payable
165
131
125
116
—
—
Cash Conversion Cycle
−87.48
−70.03
−52.95
10.99
68.3
71.23
Working Capital Days
43.32
−4.58
−33.34
21.67
114
164
ROCE %
—
32.55%
30.24%
14.81%
8.15%
7.27%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Clinitech Laboratory insights

54 extracted metrics across FY21–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 64.62%
  • Public 32.76%
  • Others 1.67%
  • DIIs 0.63%
  • FIIs 0.32%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Clinitech Laboratory

What does Clinitech Laboratory Ltd do?
Incorporated in 1990, Clinitech Laboratory Ltd is in the business of providing pathology and related healthcare services.
Where is Clinitech Laboratory Ltd (CTLLAB) listed?
Clinitech Laboratory Ltd trades under code 544220 on the BSE.
Which sector does Clinitech Laboratory Ltd belong to?
Clinitech Laboratory Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the 52-week high and low of Clinitech Laboratory Ltd?
Over the last 52 weeks Clinitech Laboratory Ltd has traded between ₹28.55 and ₹47.15 as of 30 Oct 2026.
What is the Return on Equity (ROE) of Clinitech Laboratory Ltd?
Clinitech Laboratory Ltd reported a return on equity of 4.65%. Its debt-to-equity ratio is 0.04.

Company Information

Incorporated in 1990, Clinitech Laboratory Ltd is in the business of providing pathology and related healthcare services.

Website ctllab.in
Listed 1 Aug 2024
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544220.md for Clinitech Laboratory Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month